Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$8.41+0.01 (+0.12%)
Close on Nov 13, 2026Market cap $11.80MP/E –Yield –
Aspire-Lakewood EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$16.38.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.38 | – |
| FY2024 | Dec 31, 2024 | -$1.90 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.22 | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.57 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.04 | – |
| Q2 FY2025 | Jun 30, 2025 | -$48.19 | – |
| Q1 FY2025 | Mar 31, 2025 | -$504.88 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.01 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?